Literature DB >> 10791488

Delay in treating schizophrenia may narrow therapeutic window of opportunity.

J Stephenson.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10791488     DOI： 10.1001/jama.283.16.2091

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Rapid follow-up for patients after psychiatric crisis.

Authors:  Cheryl McCullumsmith; Brendan Clark; Courtney Blair; Karen Cropsey; Richard Shelton
Journal:  Community Ment Health J       Date:  2014-11-15

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.

Authors:  Mario Alvarez-Jiménez; Alexandra G Parker; Sarah E Hetrick; Patrick D McGorry; John F Gleeson
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

4.  Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

Authors:  Miguel Camacho-Gomez; Pere Castellvi
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

5.  Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

Authors:  Kit Wa Sherry Chan; Men Heng Marian Wong; Christy Lai Ming Hui; Edwin Ho Ming Lee; Wing Chung Chang; Eric Yu Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

6.  Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.

Authors:  Nikolaos Koutsouleris; Eva M Meisenzahl; Christos Davatzikos; Ronald Bottlender; Thomas Frodl; Johanna Scheuerecker; Gisela Schmitt; Thomas Zetzsche; Petra Decker; Maximilian Reiser; Hans-Jürgen Möller; Christian Gaser
Journal:  Arch Gen Psychiatry       Date:  2009-07

Review 7.  Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

Authors:  Sabina Abidi; Irfan Mian; Iliana Garcia-Ortega; Tania Lecomte; Thomas Raedler; Kevin Jackson; Kim Jackson; Tamara Pringsheim; Donald Addington
Journal:  Can J Psychiatry       Date:  2017-08-02       Impact factor: 4.356

8.  Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.

Authors:  Erik Johnsen; Igne Sinkeviciute; Else-Marie Løberg; Rune A Kroken; Kenneth Hugdahl; Hugo A Jørgensen
Journal:  BMC Psychiatry       Date:  2013-09-30       Impact factor: 3.630

9.  Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia.

Authors:  Maria F Strømme; Liv S Mellesdal; Christoffer A Bartz-Johannesen; Rune A Kroken; Marianne L Krogenes; Lars Mehlum; Erik Johnsen
Journal:  J Clin Psychopharmacol       Date:  2022 Jan-Feb 01       Impact factor: 3.153
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.